Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
2.650
+0.080 (3.11%)
Jul 16, 2025, 4:00 PM - Market closed

Alto Neuroscience Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
160.75168.2382.5548.3425.71
Cash & Short-Term Investments
160.75168.2382.5548.3425.71
Cash Growth
-21.92%103.79%70.75%88.07%-
Accounts Receivable
----1.5
Other Receivables
---0.330.25
Receivables
---0.331.74
Prepaid Expenses
2.751.080.520.330.24
Other Current Assets
0.020.032.320.21-
Total Current Assets
163.52169.3485.3949.2227.68
Property, Plant & Equipment
7.327.71.231.581.06
Other Long-Term Assets
1.070.50.010.060.05
Total Assets
171.92177.5486.6350.8528.79
Accounts Payable
1.381.581.071.610.6
Accrued Expenses
4.977.563.53.670.93
Current Portion of Leases
0.880.870.130.28-
Other Current Liabilities
0.02-0.92-0.28
Total Current Liabilities
7.2610.015.615.561.81
Long-Term Debt
21.1511.569.869.47-
Long-Term Leases
4.414.52-0.12-
Total Liabilities
32.8226.0815.4715.151.81
Common Stock
00--0
Additional Paid-In Capital
292.64289.955.372.30.49
Retained Earnings
-153.57-138.4-76.97-40.66-12.95
Comprehensive Income & Other
0.01-0.1-0.08-0.05-0.02
Total Common Equity
139.1151.46-71.67-38.41-12.48
Shareholders' Equity
139.1151.4671.1635.7126.98
Total Liabilities & Equity
171.92177.5486.6350.8528.79
Total Debt
26.4416.949.999.87-
Net Cash (Debt)
134.32151.2972.5638.4725.71
Net Cash Growth
-31.43%108.49%88.61%49.67%-
Net Cash Per Share
4.986.1519.4511.1610.65
Filing Date Shares Outstanding
27.0727.0726.863.692.41
Total Common Shares Outstanding
27.0726.993.813.692.41
Working Capital
156.27159.3379.7843.6625.87
Book Value Per Share
5.145.61-18.81-10.40-5.17
Tangible Book Value
139.1151.46-71.67-38.41-12.48
Tangible Book Value Per Share
5.145.61-18.81-10.40-5.17
Machinery
2.722.751.271.20.88
Leasehold Improvements
0.250.25---
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q